1. Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study. (October 2017) Authors: Alù, M.; Ancona, C.; Andreis, D.; Bajardi, E.; Benedetto, C.; Berardi, R.; Bordin, E.; Butti, C.; Capri, G.; Cicchiello, F.; Cocciolone, V.; Dester, M.; D'Onofrio, L.; Febbraro, A.; Ferrarini, I.; Fotia, V.; Gervasi, E.; Guaitoli, G.; Licata, L.; Liscia, N. Journal: Breast Issue: Volume 35(2017) Page Start: 115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study. (December 2019) Authors: Cazzaniga, M.E.; Pinotti, G.; Montagna, E.; Amoroso, D.; Berardi, R.; Butera, A.; Cagossi, K.; Cavanna, L.; Ciccarese, M.; Cinieri, S.; Cretella, E.; De Conciliis, E.; Febbraro, A.; Ferraù, F.; Ferzi, A.; Fiorentini, G.; Fontana, A.; Gambaro, A.R.; Garrone, O.; Gebbia, V. Journal: Breast Issue: Volume 48(2019) Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Standard treatment in very old breast cancer patients. Recommended or not recommended?. (October 2020) Authors: Bortolini, M.; Idda, L.; Bono, D.; Trino, E.; Ragona, R.; Turletti, A.; Capello, C.; Mairone, L.; Biacchiardi, C.Perono; Guzzetti, S.; Saracco, R. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗